Systemic sclerosis (scleroderma) trials in Czechia

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

  Where

  Prague

  Age

  5 years to 80 years

  People

  1,072 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07691970
• Phase 3Not yet taking people in Czechia
  Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.

  Where

  Prague 2

  People

  340 worldwide

  Run by

  AstraZeneca AB

  See details and how to join2026-526419-13-00 · EU 2026-526419-13-00
• Phase 3Taking people
  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  Where

  Brno, Prague 2

  Age

  18 years and over

  People

  448 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07497087 · EU 2025-523884-39-00
• Phase 1Taking people
  A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  Where

  Prague, Prague 2

  Age

  18 years and over

  People

  125 worldwide

  Run by

  Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

  See details and how to joinNCT07115745 · EU 2024-517681-41-00